0001752724-24-167809.txt : 20240729 0001752724-24-167809.hdr.sgml : 20240729 20240729124838 ACCESSION NUMBER: 0001752724-24-167809 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240729 DATE AS OF CHANGE: 20240729 PERIOD START: 20250228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BNY Mellon ETF Trust CENTRAL INDEX KEY: 0001493580 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-23477 FILM NUMBER: 241150475 BUSINESS ADDRESS: STREET 1: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 BUSINESS PHONE: 212-922-6400 MAIL ADDRESS: STREET 1: 240 GREENWICH STREET CITY: NEW YORK STATE: NY ZIP: 10286 FORMER COMPANY: FORMER CONFORMED NAME: Dreyfus ETF Trust DATE OF NAME CHANGE: 20100607 0001493580 S000080184 BNY Mellon Women's Opportunities ETF C000241888 BNY Mellon Women's Opportunities ETF BKWO NPORT-P 1 primary_doc.xml NPORT-P false 0001493580 XXXXXXXX S000080184 C000241888 BNY Mellon ETF Trust 811-23477 0001493580 549300E2C8EQYJ7B0H81 240 Greenwich Street New York 10286 212-922-6400 BNY Mellon Womens Opportunities ETF S000080184 549300QAQYJD1TI1DO07 2025-02-28 2024-05-31 N 12576387.89 5355.54 12571032.35 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 UST Apple Inc HWUPKR0MPOU8FGXBT394 Apple Inc 037833100 2054.00000000 NS USD 394881.50000000 3.141201844095 Long EC CORP US N 1 N N N Alnylam Pharmaceuticals Inc 529900S3ZI14OWRJII50 Alnylam Pharmaceuticals Inc 02043Q107 480.00000000 NS USD 71246.40000000 0.566750589898 Long EC CORP US N 1 N N N Eli Lilly & Co FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co 532457108 410.00000000 NS USD 336339.40000000 2.675511371188 Long EC CORP US N 1 N N N PepsiCo Inc FJSUNZKFNQ5YPJ5OT455 PepsiCo Inc 713448108 1288.00000000 NS USD 222695.20000000 1.771494924201 Long EC CORP US N 1 N N N HubSpot Inc 529900BLNVEW0MVKJB37 HubSpot Inc 443573100 394.00000000 NS USD 240753.70000000 1.915146610850 Long EC CORP US N 1 N N N Shopify Inc 549300HGQ43STJLLP808 Shopify Inc 82509L107 4488.00000000 NS USD 265465.20000000 2.111721556424 Long EC CORP CA N 1 N N N Pinterest Inc N/A Pinterest Inc 72352L106 3204.00000000 NS USD 132933.96000000 1.057462555969 Long EC CORP US N 1 N N N Dominion Energy Inc ILUL7B6Z54MRYCF6H308 Dominion Energy Inc 25746U109 4163.00000000 NS USD 224468.96000000 1.785604823457 Long EC CORP US N 1 N N N Trane Technologies PLC 549300BURLR9SLYY2705 Trane Technologies PLC 000000000 848.00000000 NS USD 277686.08000000 2.208936165851 Long EC CORP IE N 1 N N N Workday Inc 549300J0DYC0N31V7G13 Workday Inc 98138H101 720.00000000 NS USD 152244.00000000 1.211069988217 Long EC CORP US N 1 N N N Zoetis Inc 549300HD9Q1LOC9KLJ48 Zoetis Inc 98978V103 868.00000000 NS USD 147178.08000000 1.170771627200 Long EC CORP US N 1 N N N Procter & Gamble Co/The 2572IBTT8CCZW6AU4141 Procter & Gamble Co/The 742718109 1558.00000000 NS USD 256353.32000000 2.039238408291 Long EC CORP US N 1 N N N Bright Horizons Family Solutio N/A Bright Horizons Family Solutions Inc 109194100 2156.00000000 NS USD 226638.72000000 1.802864821996 Long EC CORP US N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 Microsoft Corp 594918104 2646.00000000 NS USD 1098433.98000000 8.737818417912 Long EC CORP US N 1 N N N Lam Research Corp 549300I4GMO6D34U1T02 Lam Research Corp 512807108 168.00000000 NS USD 156649.92000000 1.246118183762 Long EC CORP US N 1 N N N Accenture PLC 5493000EWHDSR3MZWH98 Accenture PLC 000000000 761.00000000 NS USD 214822.69000000 1.708870711799 Long EC CORP IE N 1 N N N Akamai Technologies Inc OC1LZNN2LF5WTJ5RIL89 Akamai Technologies Inc 00971T101 1517.00000000 NS USD 139928.08000000 1.113099354962 Long EC CORP US N 1 N N N Caterpillar Inc WRJR7GS4GTRECRRTVX92 Caterpillar Inc 149123101 420.00000000 NS USD 142178.40000000 1.131000191881 Long EC CORP US N 1 N N N Micron Technology Inc B3DXGBC8GAIYWI2Z0172 Micron Technology Inc 595112103 1757.00000000 NS USD 219625.00000000 1.747072108998 Long EC CORP US N 1 N N N JPMorgan Chase & Co 8I5DZWZKVSZI1NUHU748 JPMorgan Chase & Co 46625H100 2252.00000000 NS USD 456322.76000000 3.629954543868 Long EC CORP US N 1 N N N Natera Inc N/A Natera Inc 632307104 668.00000000 NS USD 71162.04000000 0.566079523293 Long EC CORP US N 1 N N N AbbVie Inc FR5LCKFTG8054YNNRU85 AbbVie Inc 00287Y109 2158.00000000 NS USD 347955.92000000 2.767918420001 Long EC CORP US N 1 N N N PTC Inc 54930050SSMU8SKDJ030 PTC Inc 69370C100 658.00000000 NS USD 115965.92000000 0.922485256352 Long EC CORP US N 1 N N N Cooper Cos Inc/The QJKMVPIGLH7530PCUE20 Cooper Cos Inc/The 216648501 1652.00000000 NS USD 155800.12000000 1.239358197976 Long EC CORP US N 1 N N N FedEx Corp 549300E707U7WNPZN687 FedEx Corp 31428X106 655.00000000 NS USD 166343.80000000 1.323231023265 Long EC CORP US N 1 N N N Bank of America Corp 9DJT3UXIJIZJI4WXO774 Bank of America Corp 060505104 5483.00000000 NS USD 219265.17000000 1.744209734692 Long EC CORP US N 1 N N N Schlumberger NV 213800ZUA17OK3QLGM62 Schlumberger NV 806857108 3384.00000000 NS USD 155291.76000000 1.235314297795 Long EC CORP US N 1 N N N Mastercard Inc AR5L2ODV9HN37376R084 Mastercard Inc 57636Q104 784.00000000 NS USD 350502.88000000 2.788178967656 Long EC CORP US N 1 N N N Veralto Corp 635400FJE6GSOJUSNY27 Veralto Corp 92338C103 1031.00000000 NS USD 101635.98000000 0.808493504513 Long EC CORP US N 1 N N N Edwards Lifesciences Corp YA13X31F3V31L8TMPR58 Edwards Lifesciences Corp 28176E108 2057.00000000 NS USD 178732.73000000 1.421782436189 Long EC CORP US N 1 N N N Uber Technologies Inc 549300B2FTG34FILDR98 Uber Technologies Inc 90353T100 5337.00000000 NS USD 344556.72000000 2.740878476857 Long EC CORP US N 1 N N N CoStar Group Inc N/A CoStar Group Inc 22160N109 1779.00000000 NS USD 139064.43000000 1.106229195249 Long EC CORP US N 1 N N N Progressive Corp/The 529900TACNVLY9DCR586 Progressive Corp/The 743315103 1537.00000000 NS USD 324583.66000000 2.581996855652 Long EC CORP US N 1 N N N Lululemon Athletica Inc 549300D9GZ4BMLDW5T40 Lululemon Athletica Inc 550021109 390.00000000 NS USD 121676.10000000 0.967908574350 Long EC CORP CA N 1 N N N Walt Disney Co/The 549300GZKULIZ0WOW665 Walt Disney Co/The 254687106 1248.00000000 NS USD 129679.68000000 1.031575421886 Long EC CORP US N 1 N N N NVIDIA Corp 549300S4KLFTLO7GSQ80 NVIDIA Corp 67066G104 876.00000000 NS USD 960385.08000000 7.639667556817 Long EC CORP US N 1 N N N Meta Platforms Inc BQ4BKCS1HXDV9HN80Z93 Meta Platforms Inc 30303M102 839.00000000 NS USD 391670.37000000 3.115657959467 Long EC CORP US N 1 N N N Constellium SE 724500KRJEMC79KAAU28 Constellium SE 000000000 5856.00000000 NS USD 126899.52000000 1.009459815764 Long EC CORP FR N 1 N N N Intuit Inc VI90HBPH7XSFMB9E4M29 Intuit Inc 461202103 496.00000000 NS USD 285914.24000000 2.274389501511 Long EC CORP US N 1 N N N Boston Scientific Corp Y6ZDD9FP4P8JSSJMW954 Boston Scientific Corp 101137107 3240.00000000 NS USD 244846.80000000 1.947706387057 Long EC CORP US N 1 N N N Dreyfus Institutional Preferred Government Money Market Fund 549300RBWL04JG8SIX57 Dreyfus Institutional Preferred Government Money Market Fund 000000000 124163.57000000 NS USD 124163.57000000 0.987695891181 Long STIV RF US N 1 N N N Texas Instruments Inc WDJNR2L6D8RWOEB8T652 Texas Instruments Inc 882508104 756.00000000 NS USD 147427.56000000 1.172756189749 Long EC CORP US N 1 N N N Hologic Inc 549300DYP6F5ZJL0LB74 Hologic Inc 436440101 1816.00000000 NS USD 133984.48000000 1.065819228442 Long EC CORP US N 1 N N N Centene Corp 549300Z7JJ4TQSQGT333 Centene Corp 15135B101 2400.00000000 NS USD 171816.00000000 1.366761258871 Long EC CORP US N 1 N N N Illumina Inc SQ95QG8SR5Q56LSNF682 Illumina Inc 452327109 989.00000000 NS USD 103132.92000000 0.820401357092 Long EC CORP US N 1 N N N First Horizon Corp TF3RXI1ZB1TQ30H9JV10 First Horizon Corp 320517105 7739.00000000 NS USD 122585.76000000 0.975144734234 Long EC CORP US N 1 N N N ConocoPhillips WPTL2Z3FIYTHSP5V2253 ConocoPhillips 20825C104 1012.00000000 NS USD 117877.76000000 0.937693553863 Long EC CORP US N 1 N N N Progyny Inc N/A Progyny Inc 74340E103 5520.00000000 NS USD 148764.00000000 1.183387297543 Long EC CORP US N 1 N N N Addus HomeCare Corp 52990090ZT33AKPDBX62 Addus HomeCare Corp 006739106 1152.00000000 NS USD 132261.12000000 1.052110250913 Long EC CORP US N 1 N N N Occidental Petroleum Corp IM7X0T3ECJW4C1T7ON55 Occidental Petroleum Corp 674599105 2773.00000000 NS USD 173312.50000000 1.378665611340 Long EC CORP US N 1 N N Avantor Inc N/A Avantor Inc 05352A100 5402.00000000 NS USD 130080.16000000 1.034761158656 Long EC CORP US N 1 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 Amazon.com Inc 023135106 4280.00000000 NS USD 755163.20000000 6.007169331642 Long EC CORP US N 1 N N N 2024-07-26 BNY Mellon ETF Trust James Windels James Windels Treasurer XXXX NPORT-EX 2 647974BNYM053124.htm
STATEMENT
OF
INVESTMENTS
May
31,
2024
(Unaudited)
1
Description
Shares
Value
($)
Common
Stocks
99.0%
Banks
6.3%
Bank
of
America
Corp.
5,483
219,265
First
Horizon
Corp.
7,739
122,586
JPMorgan
Chase
&
Co.
2,252
456,323
798,174
Capital
Goods
3.3%
Caterpillar,
Inc.
420
142,178
Trane
Technologies
PLC
848
277,686
419,864
Commercial
&
Professional
Services
0.8%
Veralto
Corp.
1,031
101,636
Consumer
Discretionary
Distribution
&
Retail
6.0%
Amazon.com,
Inc.
(a)
4,280
755,163
Consumer
Durables
&
Apparel
1.0%
Lululemon
Athletica,
Inc.
(a)
390
121,676
Consumer
Services
1.8%
Bright
Horizons
Family
Solutions,
Inc.
(a)
2,156
226,639
Energy
3.6%
ConocoPhillips
1,012
117,878
Occidental
Petroleum
Corp.
(b)
2,773
173,312
Schlumberger
NV
3,384
155,292
446,482
Financial
Services
2.8%
Mastercard,
Inc.,
Class
A
784
350,503
Food,
Beverage
&
Tobacco
1.8%
PepsiCo,
Inc.
1,288
222,695
Health
Care
Equipment
&
Services
9.3%
Addus
HomeCare
Corp.
(a)
1,152
132,261
Boston
Scientific
Corp.
(a)
3,240
244,847
Centene
Corp.
(a)
2,400
171,816
Cooper
Cos.,
Inc.
(The)
1,652
155,800
Edwards
Lifesciences
Corp.
(a)
2,057
178,733
Hologic,
Inc.
(a)
1,816
133,984
Progyny,
Inc.
(a)
5,520
148,764
1,166,205
Household
&
Personal
Products
2.0%
Procter
&
Gamble
Co.
(The)
1,558
256,353
STATEMENT
OF
INVESTMENTS
(continued)
2
Description
Shares
Value
($)
Common
Stocks
99.0%
(continued)
Insurance
2.6%
Progressive
Corp.
(The)
1,537
324,584
Materials
1.0%
Constellium
SE
(a)
5,856
126,900
Media
&
Entertainment
5.2%
Meta
Platforms,
Inc.,
Class
A
839
391,670
Pinterest,
Inc.,
Class
A
(a)
3,204
132,934
Walt
Disney
Co.
(The)
1,248
129,680
654,284
Pharmaceuticals,
Biotechnology
&
Life
Sciences
9.6%
AbbVie,
Inc.
2,158
347,956
Alnylam
Pharmaceuticals,
Inc.
(a)
480
71,247
Avantor,
Inc.
(a)
5,402
130,080
Eli
Lilly
&
Co.
410
336,339
Illumina,
Inc.
(a)
989
103,133
Natera,
Inc.
(a)
668
71,162
Zoetis,
Inc.,
Class
A
868
147,178
1,207,095
Real
Estate
Management
&
Development
1.1%
CoStar
Group,
Inc.
(a)
1,779
139,064
Semiconductors
&
Semiconductor
Equipment
11.8%
LAM
Research
Corp.
168
156,650
Micron
Technology,
Inc.
1,757
219,625
NVIDIA
Corp.
876
960,385
Texas
Instruments,
Inc.
756
147,428
1,484,088
Software
&
Services
20.0%
Accenture
PLC,
Class
A
761
214,823
Akamai
Technologies,
Inc.
(a)
1,517
139,928
HubSpot,
Inc.
(a)
394
240,754
Intuit,
Inc.
496
285,914
Microsoft
Corp.
2,646
1,098,434
PTC,
Inc.
(a)
658
115,966
Shopify,
Inc.,
Class
A
(a)
4,488
265,465
Workday,
Inc.,
Class
A
(a)
720
152,244
2,513,528
Technology
Hardware
&
Equipment
3.1%
Apple,
Inc.
2,054
394,881
Transportation
4.1%
FedEx
Corp.
655
166,344
Uber
Technologies,
Inc.
(a)
5,337
344,557
510,901
3
See
Notes
to
Statement
of
Investments
Description
Shares
Value
($)
Common
Stocks
99.0%
(continued)
Utilities
1.8%
Dominion
Energy,
Inc.
4,163
224,469
Total
Common
Stocks
(cost
$9,960,319)
12,445,184
Investment
Companies
1.0%
Registered
Investment
Companies
1.0%
Dreyfus
Institutional
Preferred
Government
Money
Market
Fund,
Institutional
Shares,
5.28%
(c)(d)
(cost
$124,164)
124,164
124,164
Total
Investments
(cost
$10,084,483)
100.0%
12,569,348
Cash
and
Receivables
(Net)
0.0%
1,684
Net
Assets
100.0%
12,571,032
(a)
Non-income
producing
security.
(b)
Security,
or
portion
thereof,
on
loan.
At
May
31,
2024,
the
value
of
the
fund’s
securities
on
loan
was
$171,563
and
the
value
of
the
collateral
was
$171,871,
consisting
of
U.S.
Government
&
Agency
securities.
In
addition,
the
value
of
collateral
may
include
pending
sales
that
are
also
on
loan.
(c)
Investment
in
affiliated
issuer.
The
investment
objective
of
this
investment
company
is
publicly
available
and
can
be
found
within
the
investment
company’s
prospectus.
(d)
The
rate
shown
is
the
1-day
yield
as
of
May
31,
2024.
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
4
The
Financial
Accounting
Standards
Board
(“FASB”)
Accounting
Standards
Codification
(“ASC”)
is
the
exclusive
reference
of
authoritative
U.S.
generally
accepted
accounting
principles
(“GAAP”)
recognized
by
the
FASB
to
be
applied
by
nongovernmental
entities.
Rules
and
interpretive
releases
of
the
Securities
and
Exchange
Commission
(“SEC”)
under
authority
of
federal
laws
are
also
sources
of
authoritative
GAAP
for
SEC
registrants. BNY
Mellon
Women's
Opportunities
ETF (the
“fund”)
is an
investment
company
and
applies
the
accounting
and
reporting
guidance
of
the
FASB
ASC
Topic
946
Financial
Services-Investment
Companies. The
fund’s
financial
statements
are
prepared
in
accordance
with
GAAP,
which
may
require
the
use
of
management
estimates
and
assumptions.
Actual
results
could
differ
from
those
estimates.  
(a)
Portfolio
valuation:
The
fair
value
of
a
financial
instrument
is
the
amount
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date
(i.e.,
the
exit
price).
GAAP
establishes
a
fair
value
hierarchy
that
prioritizes
the
inputs
of
valuation
techniques
used
to
measure
fair
value.
This
hierarchy
gives
the
highest
priority
to
unadjusted
quoted
prices
in
active
markets
for
identical
assets
or
liabilities
(Level
1
measurements)
and
the
lowest
priority
to
unobservable
inputs
(Level
3
measurements).
Additionally,
GAAP
provides
guidance
on
determining
whether
the
volume
and
activity
in
a
market
has
decreased
significantly
and
whether
such
a
decrease
in
activity
results
in
transactions
that
are
not
orderly.
GAAP
requires
enhanced
disclosures
around
valuation
inputs
and
techniques
used
during
annual
and
interim
periods.
Various
inputs
are
used
in
determining
the
value
of
the
fund’s
investments
relating
to
fair
value
measurements.
These
inputs
are
summarized
in
the
three
broad
levels
listed
below:
Level
1
unadjusted
quoted
prices
in
active
markets
for
identical
investments.
Level
2
other
significant
observable
inputs
(including
quoted
prices
for
similar 
investments,
interest
rates,
prepayment
speeds,
credit
risk,
etc.).
Level
3
significant
unobservable
inputs
(including
the
fund’s
own
assumptions
in
determining
the
fair
value
of
investments).
The
inputs
or
methodology
used
for
valuing
securities
are
not
necessarily
an
indication
of
the
risk
associated
with
investing
in
those
securities.
Changes
in
valuation
techniques
may
result
in
transfers
in
or
out
of
an
assigned
level
within
the
disclosure
hierarchy.
Valuation
techniques
used
to
value
the
fund’s
investments
are
as
follows:
5
BNY
Mellon
ETF
Trust’s
(the
“Trust”) Board
of
Trustees
(the
“Board”)
has
designated
the
Adviser
as
the
fund’s
valuation
designee
to
make
all
fair
value
determinations
with
respect
to
the
fund’s
portfolio
of
investments,
subject
to
the
Board’s
oversight
and
pursuant
to
Rule
2a-5
under
the
Act.
Investments
in
equity
securities,
including
ETFs
(but
not
including
investments
in
other
open-end
registered
investment
companies),
generally
are
valued
at
the
last
sales
price
on
the
day
of
valuation
on
the
securities
exchange
or
national
securities
market
on
which
such
securities
primarily
are
traded.
Securities
listed
on
the
National
Association
of
Securities
Dealers
Automated
Quotation
System
(“NASDAQ”)
for
which
market
quotations
are
available
will
be
valued
at
the
official
closing
price.
If
there
are
no
transactions
in
a
security,
or
no
official
closing
prices
for
a
NASDAQ
market-listed
security
on
that
day,
the
security
will
be
valued
at
the
average
of
the
most
recent
bid
and
asked
prices.
Bid
price
is
used
when
no
asked
price
is
available.
Open
short
positions
for
which
there
is
no
sale
price
on
a
given
day
are
valued
at
the
lowest
asked
price.
Registered
investment
companies
that
are
not
traded
on
an
exchange
are
valued
at
their
net
asset
value.
All
of
the
preceding
securities
are
generally
categorized
within
Level
1
of
the
fair
value
hierarchy. 
When
market
quotations
or
official
closing
prices
are
not
readily
available,
or
are
determined
not
to
reflect
fair
value
accurately,
they are
valued
at
fair
value
as
determined
in
good
faith
based
on
procedures
approved
by
the
Board.
Fair
value
of
investments
may
be
determined
by
valuation
designee
using
such
information
as
it
deems
appropriate
under
the
circumstances.
Certain
factors
may
be
considered
when
fair
valuing
investments
such
as:
fundamental
analytical
data,
the
nature
and
duration
of
restrictions
on
disposition,
an
evaluation
of
the
forces
that
influence
the
market
in
which
the
securities
are
purchased
and
sold,
and
public
trading
in
similar
securities
of
the
issuer
or
comparable
issuers.
These
securities
are
either
categorized
within
Level
2
or
3
of
the
fair
value
hierarchy
depending
on
the
relevant
inputs
used.
For
securities
where
observable
inputs
are
limited,
assumptions
about
market
activity
and
risk
are
used
and
are
generally
categorized
within
Level
3
of
the
fair
value
hierarchy.
The
table
below
summarizes
the
inputs
used
as
of May
31,
2024
in
valuing
the
fund’s
investments:
NOTES
TO
STATEMENT
OF
INVESTMENTS
(Unaudited)
(continued)
6
Fair
Value
Measurements
Pursuant
to
a
securities
lending
agreement
with
BNY
Mellon,
the
fund
may
lend
securities
to
qualified
institutions.
It
is
the
fund’s
policy
that,
at
origination,
all
loans
are
secured
by
collateral
of
at
least
102%
of
the
value
of
U.S.
securities
loaned
and
105%
of
the
value
of
foreign
securities
loaned.
Collateral
equivalent
to
at
least
100%
of
the
market
value
of
securities
on
loan
is
maintained
at
all
times.
Collateral
is
either
in
the
form
of
cash,
which
can
be
invested
in
certain
money
market
mutual
funds
managed
by
the
Adviser,
or
U.S.
Government
and
Agency
securities.
The
fund
is
entitled
to
receive
all
dividends,
interest
and
distributions
on
securities
loaned,
in
addition
to
income
earned
as
a
result
of
the
lending
transaction.
Should
a
borrower
fail
to
return
the
securities
in
a
timely
manner,
The
Bank
of
New
York
Mellon
is
required
to
replace
the
securities
for
the
benefit
of
the
fund
or
credit
the
fund
with
the
market
value
of
the
unreturned
securities
and
is
subrogated
to
the
fund’s
rights
against
the
borrower
and
the
collateral.
Additionally,
the
contractual
maturity
of
security
lending
transactions
are
on
an
overnight
and
continuous
basis.
Additional
investment
related
disclosures
are
hereby
incorporated
by
reference
to
the
annual
and
semi-annual
reports
previously
filed
with
the
SEC
on
Form
N-CSR.
At May
31,
2024,
accumulated
net
unrealized
appreciation on
investments
was
$2,484,865,
consisting
of
gross
appreciation
of
$2,791,781
and
gross
depreciation
of
$306,916.
At
May
31,
2024,
the
cost
of
investments
for
federal
income
tax
purposes
was
substantially
the
same
as
the
cost
for
financial
reporting
purposes
(see
the
Statement
of
Investments).
Level
1
-
Unadjusted
Quoted
Prices
Level
2
-
Other
Significant
Observable
Inputs
Level
3
-
Significant
Unobservable
Inputs
Total
Assets
($)
Investments
In
Securities:
Common
Stocks
12,445,184
12,445,184
Investment
Companies
124,164
124,164
See
Statement
of
Investments
for
additional
detailed
categorizations,
if
any.